FAIRCHEMOR Fairchem Organics Q4 FY26 results (Jan–Mar 2026) and concall
Fairchem Organic reported a mixed Q4 FY26 with a revenue decline of 3.2% YoY to Rs. 117 crores, but a significant improvement in EBITDA margin to 6.9% driven by better price realization and reduced Chinese dumping. The company completed a share buyback, increasing promoter holding. Management provided an optimistic outlook, targeting 8% EBIT margins, 95% capacity utilization, and a substantial increase in export contribution, supported by new product introductions and ongoing cost efficiencies.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 3.3%, net profit up 300.0% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 114 | 121 | 131 | 112 | 100 −12% | 117 −3% |
| EBITDA | 8 | 4 | 5 | 4 | 4 −50% | 8 +100% |
| Net profit | 4 | 1 | 1 | 1 | 0 −100% | 4 +300% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
